D24410514A_Response_Package_HTH-2014-00052.PDF
D24410714A_Response_Letter_HTH-2014-00052.PDF
FOI Request - HTH-2014-00052 A list of all pharmaceutical products and their manufacturers which have or have had a Product Listing Agreement (PLA) with the Ministry within the past five years; [A copy of] the PLAs currently in effect for the following seven products for any strength or dosage form; Wellbutrin XL (generic name Bupropion HCL), Ativan (generic name Lorazepam), Nitro-Dur (generic name Nitroglycerin), Accupril (generic name Quinapril), Serquel XR (generic name Quietiapine XR), Nexium (generic name Esomeprazole Magnesium) and Reminyl ER (generic name Galantamine HBR). FOI Request FOI Request 2014-04-29 Health 4 2014 D24410714A_Response_Letter_HTH-2014-00052.PDF D24410514A_Response_Package_HTH-2014-00052.PDF Law Firm $0.00